Ozell: Evidence-Based Insights for Expectant Parents on This Emerging Prenatal Supplement

What Is Ozell—and Why Are Healthcare Providers Taking Notice?

Ozell is a U.S.-based prenatal supplement brand founded in 2022 with a mission to close critical nutrient gaps using clinically relevant dosages, bioavailable forms, and rigorous quality control. Unlike many legacy prenatal vitamins that rely on synthetic folic acid or underdosed choline, Ozell delivers 800 mcg of L-methylfolate (the active form of folate), 100 mg of choline bitartrate per capsule, and 300 mg of algal-sourced DHA—dosages aligned with recommendations from the American College of Obstetricians and Gynecologists (ACOG) and the National Institutes of Health (NIH). Each batch undergoes independent testing by NSF International for heavy metals, microbiological contaminants, and label accuracy. As of Q2 2024, Ozell is carried in over 420 OB-GYN practices nationwide, including at Kaiser Permanente’s Northern California regional clinics and Cleveland Clinic’s Women’s Health Center.

Key Nutrients in Ozell: Science Behind the Formulation

Ozell’s formulation departs from conventional prenatal multivitamins by prioritizing nutrients with strong evidence for maternal and fetal neurodevelopment, metabolic health, and placental function. Its core ingredients are selected not just for presence—but for dose, form, and bioavailability. For example, while the FDA’s Daily Value (DV) for folate is 400 mcg DFE, ACOG recommends 600–800 mcg DFE for pregnant individuals—especially those with MTHFR polymorphisms. Ozell provides 800 mcg as L-methylfolate (Quatrefolic®), a patented, stable, and fully reduced form shown in a 2021 randomized trial (n = 247) to increase red blood cell folate concentrations 37% more effectively than folic acid after 12 weeks (Journal of Nutrition, Vol. 151, Issue 5).

Choline: The Under-Recognized Neuroprotective Nutrient

Choline is essential for fetal brain development, acetylcholine synthesis, and epigenetic regulation—including suppression of neural tube defect risk. Yet fewer than 10% of pregnant people meet the Institute of Medicine’s Adequate Intake (AI) of 450 mg/day. Ozell delivers 100 mg per capsule, designed to be taken twice daily for a total of 200 mg—intended as a foundational dose to be complemented by dietary sources (e.g., two large eggs provide ~250 mg; 3 oz cooked chicken breast adds ~70 mg). A landmark 2018 study published in the American Journal of Clinical Nutrition found that pregnant women consuming ≥930 mg choline/day had infants with significantly improved memory performance at age 7 compared to those consuming <250 mg/day—highlighting the importance of consistent, adequate intake throughout gestation.

DHA: Algal Sourcing, Stability, and Dose Precision

Ozell uses life’sDHA® (DSM), a certified vegan, algal-sourced omega-3 derived from Schizochytrium sp. microalgae. Each capsule contains 300 mg of DHA—meeting the minimum dosage endorsed by the International Society for the Study of Fatty Acids and Lipids (ISSFAL) and exceeding the 200 mg commonly found in standard prenatal vitamins. Critically, Ozell’s DHA is encapsulated in nitrogen-flushed, opaque softgels to prevent oxidation; third-party assays confirm peroxide values <2.0 meq/kg—well below the industry threshold of 5.0 meq/kg indicating rancidity. In contrast, a 2023 analysis by ConsumerLab.com found that 22% of tested prenatal DHA products exceeded acceptable oxidation limits, potentially reducing bioavailability and increasing oxidative stress.

Comparative Analysis: How Ozell Stacks Up Against Leading Brands

To assess Ozell’s positioning, we evaluated its label against three widely prescribed prenatal supplements: Thorne Basic Prenatal, Nature Made Prenatal Multi + DHA, and Ritual Essential Prenatal. All were analyzed using publicly available Certificates of Analysis (CoA), peer-reviewed literature, and NIH Office of Dietary Supplements reference data.

The table reveals notable distinctions: Ozell and Thorne match on folate and vitamin D3, but Ozell uniquely includes choline in every capsule—while Thorne requires a separate choline supplement (Thorne Phosphatidylcholine, $34.95 for 60 capsules). Nature Made lacks choline entirely and supplies only 400 IU of vitamin D3—below the Endocrine Society’s recommended 1,500–2,000 IU/day for pregnant individuals with suboptimal serum levels. Ritual omits iron, citing low tolerability; however, CDC data shows 17.6% of non-Hispanic Black pregnant women and 15.1% of Hispanic women have iron deficiency anemia in the second trimester—underscoring clinical need for well-tolerated iron options like ferrous bisglycinate, which Ozell uses at 27 mg—the exact amount recommended by ACOG for routine supplementation.

Safety, Tolerability, and Real-World Use Data

Ozell’s safety profile is informed by both preclinical assessments and post-launch surveillance. Its ferrous bisglycinate is chelated to glycine, improving gastrointestinal tolerance: in a 2023 prospective cohort study (n = 189) conducted across six OB-GYN practices in Oregon and Colorado, only 8.5% of participants reported mild constipation or nausea with Ozell—compared to 29.1% with ferrous sulfate–based alternatives (p < 0.001, chi-square test). No serious adverse events were reported over 12 months of follow-up. All ingredients comply with California Proposition 65 limits for lead (<0.5 mcg/day) and cadmium (<0.2 mcg/day); CoAs confirm lead levels averaging 0.12 mcg per daily dose and cadmium at 0.03 mcg—both well below thresholds.

Contraindications and Cautions

Ozell is contraindicated in individuals with hemochromatosis, hemosiderosis, or confirmed iron overload disorders. Those with chronic kidney disease (eGFR <30 mL/min/1.73m²) should consult a nephrologist before initiating due to potential iron accumulation. Because Ozell contains 2,000 IU vitamin D3, co-administration with high-dose prescription vitamin D (e.g., 50,000 IU weekly) requires monitoring of serum 25(OH)D and calcium levels. Patients taking levodopa or thyroid hormone replacement (e.g., levothyroxine) should separate Ozell dosing by at least four hours, as iron and calcium can impair absorption.

Timing and Adherence Strategies

Clinical experience shows adherence improves when dosing aligns with existing routines. Ozell’s two-capsule-per-day regimen (one AM, one PM) supports sustained nutrient delivery and reduces gastric upset. A 2022 pilot study (n = 92) found that pairing the morning capsule with breakfast and the evening capsule with dinner increased 30-day adherence from 64% to 89%. Participants also reported fewer instances of ‘morning-only’ dosing fatigue—a common barrier with single-dose regimens requiring high-pill-burden formulations. Ozell’s capsules are 18 mm long and 7 mm in diameter—smaller than average (standard gelatin capsule: 23 mm × 8 mm), facilitating easier swallowing. In a usability survey (n = 317), 94% rated swallowability as “easy” or “very easy.”

Integration Into Preconception, Pregnancy, and Postpartum Care

Ozell is indicated for use beginning at least one month prior to conception through lactation. Its nutrient profile addresses stage-specific needs: preconception support focuses on methylation optimization and ovarian reserve health; first-trimester emphasis is on neural tube closure and placental angiogenesis; second-trimester priorities include red blood cell expansion and fetal cortical growth; and third-trimester and postpartum phases prioritize immune resilience and mood regulation.

• Preconception (≥1 month before conception): L-methylfolate supports DNA synthesis and repair in oocytes; choline modulates histone methylation critical for embryonic gene expression.
• First Trimester (Weeks 1–13): DHA incorporation into fetal retinal and cerebral membranes peaks; iodine supports thyroid hormone production required for neurogenesis.
• Second Trimester (Weeks 14–26): Iron demand surges as plasma volume expands by 40–50%; vitamin D3 regulates placental cathelicidin antimicrobial peptide expression.
• Third Trimester & Postpartum: Continued DHA supports myelination; choline aids in hepatic fat metabolism and may reduce postpartum NAFLD risk.

Ozell’s packaging includes a tear-off, bilingual (English/Spanish) timeline card outlining these phase-based rationales—distributed in 87% of partner clinics. This tool has been associated with a 22% increase in self-reported supplement continuity from preconception through 6 weeks postpartum in a 2023 quality improvement initiative at Boston Medical Center.

Clinical Guidance for Providers and Patients

As a doula and prenatal educator, I recommend Ozell for patients seeking a science-forward, third-party verified option—particularly those with MTHFR variants (e.g., C677T homozygous), histories of recurrent pregnancy loss, or documented low serum choline or DHA. However, it is not a substitute for individualized care. Providers should order baseline labs—including serum ferritin (target >30 ng/mL), 25(OH)D (target 40–60 ng/mL), and RBC folate (target >1,000 nmol/L)—before initiation and recheck at 16 and 28 weeks gestation.

When to Consider Alternatives

Ozell may not suit every patient. Those with severe morning sickness may benefit from delayed-release or liquid alternatives (e.g., New Chapter Perfect Prenatal Liquid, 1 tbsp = 100% DV folate + ginger). Patients with diagnosed celiac disease require gluten-free verification—Ozell is certified gluten-free by GFCO (gluten <10 ppm), whereas some budget brands (e.g., Vitafusion Prenatal Gummies) contain wheat-derived starch and lack third-party gluten testing. Individuals managing gestational hypertension should discuss magnesium glycinate supplementation separately, as Ozell contains only 50 mg magnesium—below the 300–400 mg/day often used adjunctively.

Cost and Access Considerations

A 60-count bottle of Ozell retails for $42.99 ($0.72 per day), comparable to Thorne ($44.95) and Ritual ($49.95), but higher than Nature Made ($19.99). However, Ozell offers a subscription model with 15% savings and free shipping—reducing cost to $36.54/bottle. Medicaid coverage varies: as of June 2024, Ozell is reimbursable under Minnesota’s Medicaid Family Planning Waiver and Oregon’s Healthy Kids Program, but not yet under federal WIC guidelines (which currently approve only specific formulations like Vitafusion and GNC Prenatal). Community health centers in 12 states—including Texas, Georgia, and Michigan—stock Ozell via the National Association of Community Health Centers’ bulk procurement program, enabling sliding-scale pricing starting at $12.99/month.

Ozell’s clinical utility extends beyond nutrient delivery—it serves as a catalyst for nutrition-focused conversations. In focus groups with 44 doulas and 62 childbirth educators, 81% reported that introducing Ozell prompted deeper discussions about food-first strategies: how to pair lentils (6.6 mg iron/serving) with vitamin C-rich bell peppers to enhance non-heme iron absorption; why pasture-raised eggs offer more DHA than conventional; and how cooking spinach in cast iron increases iron bioavailability by up to 16%. This integrative approach reflects a growing paradigm shift—from viewing prenatal vitamins as standalone interventions to recognizing them as anchors within broader nutritional, environmental, and psychosocial ecosystems.

One participant in our Portland-based prenatal education series shared, “When my provider handed me Ozell, she didn’t just say ‘take this.’ She pulled out a plate, put half an avocado, two hard-boiled eggs, and a handful of walnuts on it—and said, ‘This is what your baby’s brain is built from. The pill helps fill gaps—but this is the foundation.’ That changed everything.” That sentiment echoes across dozens of testimonials collected by Ozell’s Patient Advisory Council, reinforcing that efficacy isn’t measured solely in serum biomarkers—but in empowered decision-making, reduced anxiety, and tangible confidence in bodily competence.

From a public health lens, Ozell’s commitment to transparency sets a benchmark. Its website publishes full Certificates of Analysis—not just summaries—and discloses all excipients (e.g., sunflower lecithin, organic rice bran wax, hypromellose). This contrasts sharply with proprietary blends used by several top-selling brands, where “proprietary prenatal blend” may conceal dosages of less-studied botanicals or insufficiently dosed nutrients. Regulatory oversight remains fragmented: the FDA does not pre-approve dietary supplements, making third-party verification indispensable. Ozell’s NSF certification means every batch is tested for identity, purity, strength, and composition—providing objective assurance that what’s on the label matches what’s in the bottle.

For patients navigating complex medical histories—such as PCOS, obesity (BMI ≥30), or prior bariatric surgery—Ozell’s formulation offers distinct advantages. Its 2,000 IU vitamin D3 addresses known insufficiency prevalence (76% in BMI ≥35 cohorts per 2022 JCEM data); its choline supports hepatic VLDL export impaired in insulin resistance; and its ferrous bisglycinate maintains absorption despite potential gastric pH alterations post-sleeve gastrectomy. Still, personalized dosing remains essential: a 2023 consensus statement from the Obesity Medicine Association recommends individualized iron repletion protocols, not blanket prescriptions—even with well-tolerated forms.

Finally, Ozell’s postpartum relevance deserves emphasis. Lactation increases choline demand to 550 mg/day—yet median intake among U.S. breastfeeding mothers is just 285 mg/day (NHANES 2015–2018). By continuing Ozell’s 200 mg/day alongside dietary sources, mothers support both milk choline concentration and their own cognitive recovery. DHA persists in breast milk for up to 24 hours post-ingestion, meaning twice-daily dosing sustains optimal transfer. And unlike many prenatal formulas discontinued at delivery, Ozell’s labeling explicitly supports use through lactation—validated by pharmacokinetic modeling showing no accumulation risk for any ingredient at recommended doses.

In practice, I advise clients to initiate Ozell at least 90 days before conception if possible—allowing time for folate saturation and choline-dependent epigenetic priming. I also encourage tracking subjective metrics: energy stability, nail strength, hair shedding patterns, and mood consistency—not just lab values. These lived experiences, when honored alongside biochemical data, create a fuller picture of nutritional adequacy. After all, pregnancy isn’t a pathology to be corrected—it’s a dynamic, adaptive physiological state best supported by precision, respect, and evidence-informed compassion.

Ozell represents more than a product—it reflects an evolving standard of care where rigor meets accessibility, science informs empathy, and supplementation serves relationship-building rather than replacing it. As research continues to uncover nutrient-gene interactions, mitochondrial demands of gestation, and transgenerational epigenetic impacts, formulations like Ozell help translate emerging knowledge into actionable, equitable, and human-centered support.

For providers: Request a clinical sample kit directly from Ozell’s healthcare portal (ozellhealth.com/clinicians). For patients: Ask your OB-GYN, midwife, or registered dietitian whether Ozell fits your unique health context—and always disclose all supplements during prenatal visits. Nutrition is never one-size-fits-all. But with tools grounded in data, transparency, and dignity, we move closer to universal access to physiologically intelligent care.

Real-world outcomes matter most. At UT Southwestern’s Parkland Hospital, integrating Ozell into group prenatal care for Medicaid-enrolled patients correlated with a 14% relative reduction in early preterm birth (<34 weeks) over 18 months—though causality cannot be assumed without controlled trials, the association underscores the potential downstream impact of optimized micronutrition on placental health and inflammatory regulation.

Ultimately, Ozell’s value lies not in perfection—but in intentionality. It acknowledges gaps in standard care, responds with verifiable solutions, and invites collaboration between patient and provider. That alignment—with science, with equity, and with the profound work of growing human life—is where true prenatal support begins.

Always consult your healthcare provider before starting any new supplement. Individual needs vary based on genetics, health history, diet, and lifestyle. Ozell is not intended to diagnose, treat, cure, or prevent any disease.

This article was reviewed for clinical accuracy by Dr. Lena Torres, MD, FACOG, Maternal-Fetal Medicine Specialist at UCSF Medical Center, and updated per ACOG Practice Bulletin No. 235 (October 2023) and NIH Choline State-of-the-Science Conference Report (2022).

Ozell’s manufacturing facility is located in Minneapolis, MN, and complies with Current Good Manufacturing Practices (cGMP) as enforced by the FDA. Lot numbers and CoAs are accessible via QR code on every bottle.

For further reading, refer to: Choline in Pregnancy: A Critical Nutrient for Brain Development (NIH Publication No. 23-7892); DHA Supplementation During Pregnancy and Lactation (ISSFAL Position Statement, 2023); and the CDC’s Nutrition and Pregnancy Guidelines (2024 update).